We highlight the most frequently mutated genes (TP53, EGFR, KRAS, CDKN2A, and STK11) and most frequently reported missense mutations (L858R in EGFR and G12C in KRAS) in BM derived from NSCLC, and assessed their potential clinical actionability. Here, CDKN2A is linked to non-small cell lung carcinoma.